COMMUNIQUÉS West-GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences
11/11/2025
CARLSBAD, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced that management will participate in the following upcoming investor conferences: [...]
Precision Optics Announces Product Development Agreement to Develop Custom High-End Borescope for Jet Engines
11/11/2025
GARDNER, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, [...]
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
11/11/2025
SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two [...]
Healios K.K. to Present at Jefferies Global Healthcare Conference
11/11/2025
NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the Jefferies Global Healthcare Conference in London as follows [...]
Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences
11/11/2025
NEW HOPE, Pa., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through [...]
Gnome Sciences Announces Cancer Drug Shows Promise in Stopping Progression of ALS
11/11/2025
Research suggests BCL2 inhibitors may treat neurodegenerative diseases COLUMBUS, Ohio, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Gnome Sciences, a molecular pathology and translational research services company, announced a [...]
March Biosciences Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for MB-105 in Relapsed/Refractory CD5-Positive T-Cell Lymphoma
11/11/2025
HOUSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food and Drug [...]
Prime Medicine to Present at Jefferies Global Healthcare Conference
11/11/2025
CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
Oncotelic Therapeutics and Sapu Bioscience Announce Publication on Sub-15 nm Nanoparticles in International Journal of Molecular Sciences
11/11/2025
Breakthrough Review Defines the Next Frontier in Precision Nanomedicine Agoura Hills, CA, and San Diego, CA, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics Inc. (OTLC) and JV partner Sapu Bioscience today [...]
Palvella Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/11/2025
Palvella’s recently expanded rare disease pipeline now comprises QTORIN™-derived product candidates advancing in four serious, rare skin diseases that currently have no FDA-approved therapies Top-line results for fully [...]
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highlights
11/11/2025
R evenue increase d 29% to $ 13.5 million in Q3 2025 as compared with Q 3 202 4 Operating income totaled $ 1. 3 million and Adjusted EBITDA rose approximately 80% to $ 2.0 million in Q3 2025, as compared with Q3 2024 [...]
CorVel Earns Spot on TIME’s America’s Growth Leaders 2026 List — the Only Company in Its Industry Recognized
11/11/2025
Recognition reflects CorVel’s sustained growth, financial strength, and market performance FORT WORTH, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Today, CorVel Corporation (NASDAQ: CRVL), a national provider of risk [...]
Zenas BioPharma to Present at Upcoming Healthcare Investor Conferences
11/11/2025
WALTHAM, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
11/11/2025
FRIENDSWOOD, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management [...]
Flower by Edie Parker Announces Exclusive Partnership with Verano to Launch Cannabis Line in Florida with Campaign Starring Miami Native and Grammy-Nominated Rapper JT
11/11/2025
NEW YORK, NY, & CHICAGO, IL, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Edie Parker (the “Company”), a leading female founded, female operated lifestyle brand merging the worlds of fashion and cannabis, today announced an [...]
Solésence Reports Third Quarter 2025 Financial Results
11/11/2025
Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in [...]
New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans
11/11/2025
Prospective study data and retrospective registry data were analyzed in the manuscripts recently published by the Journal of Cataract and Refractive Surgery, Journal of Glaucoma and Clinical Ophthalmology MENLO PARK, [...]
Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
11/11/2025
REDWOOD CITY, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today [...]
Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value
11/11/2025
Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LP No Stockholder Action Required at This Time BURLINGTON, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Neuphoria [...]

Pages